Brompheniramine and chlorpheniramine have anticholinergic activities, but the relative potency of these effects has not been well defined. The anticholinergic properties of brompheniramine, chlorpheniramine, and atropine were assessed in an in vitro model of human nasal mucosal glandular secretion. Methacholine was used as a cholinergic agonist to stimulate glandular secretion of 7F10-mucin. These drugs (0.01–1000 μM) or vehicle (saline) were added to explant cultures with and without 100 μM methacholine. 7F10-mucin concentrations were measured in culture supernatants after 2-hour incubations. The effective dose reducing methacholine-induced secretion (ED50) was determined. ED50 was 0.25 μM for atropine, 4.10 μM for brompheniramine, and 4.63 μM for chlorpheniramine. None of the anticholinergic drugs changed spontaneous glandular exocytosis. Brompheniramine and chlorpheniramine are equipotent anticholinergic agents in human nasal mucosa in vitro. Atropine was 16 to 19 times more potent.
Get full access to this article
View all access options for this article.
References
1.
KuboN., ShirakawaO., KunoT., TanakaC.Antimuscarinic effects of antihistamines: Quantitative evaluation by receptor binding assays.Jpn J Pharmacol43: 277–282, 1987.
2.
DoyleW.J., McBrideT.P., SkonerD.P.A double-blind, placebo-controlled clinical trial of the effect of chlorpheniramine on the response of the nasal airway, middle ear, and eustachian tube to provocative rhinovirus challenge.Pediatr Infect Dis J7: 229–238, 1988.
3.
GaffeyM.J., GwaltneyJ.M.Jr., SastreA.Intranasally and orally administered antihistamine treatment of experimental rhinovirus colds.Am Rev Respir Dis136: 556–560, 1987.
4.
VirtanenH.A slow release combined preparation (dexchlorpheniramine + pseudoephedrine) for symptomatic treatment of the common cold.J Laryngol Otol (England)97: 159–163, 1983.
5.
CrutcherJ.E., KantnerT.R.The effectiveness of antihistamines in the common cold.J Clin Pharmacol21: 9–15, 1981.
6.
HowardJ.C.Jr., KantnerT.R., LilienfieldL.S., PrinciottoJ.V., KrumR.E., CrutcherJ.E., BelmanM.A., DanzigM.R.Effectiveness of antihistamines in the symptomatic management of the common cold.JAMA242: 2414–2417, 1979.
7.
LuksD., AndersonM.R.Antihistamines and the common cold: A review and critique of the literature.J Gen Intern Med11: 240–244, 1996.
8.
GwaltneyJ.M.Jr., ParkJ., PaulR.A.Randomized controlled trial of clemastine fumarate for treatment of experimental rhinovirus colds.Clin Inf Dis22: 656–662, 1996.
9.
EcclesR., an CauwenbergeP., TetzloffW., BorumP.A clinical study to evaluate the efficacy of the antihistamine doxylamine succinate in the relief of runny nose and sneezing associated with upper respiratory tract infection.J Pharm Pharmacol47: 990–993, 1995.
10.
RaphaelG.D., IgarashiY., WhiteM.V., KalinerM.A.The pathophysiology of rhinitis. V. Sources of protein in allergen-induced nasal secretions.J Allergy Clin Immunol88: 33–43, 1991.
BaraniukJ.N., SilverP.B., KalinerM.A., BarnesP.J.Effects of ipratropium bromide on bradykinin nasal provocation in humans.Clin Exp Allergy14: 724–729, 1994.
14.
RaphaelG.D., DruceH.M., BaraniukJ.N., KalinerM.A.Pathophysiology of rhinitis. I. Assessment of the sources of protein in methacholine-induced nasal secretions.Am Rev Respir Dis138: 413–420, 1988.
15.
AliM., ManiscalcoJ., BaraniukJ.N.Spontaneous release of submucosal gland serous and mucous cell macromolecules from human nasal explants in vitro.Am J Physiol (Lung Cell Mol Physiol)14: L595–L600, 1996.
16.
MullolJ., BaraniukJ.N., LogunC.M1 and M3 muscarinic antagonists inhibit human nasal glandular secretion in vitro.J Appl Physiol73: 2069–2073, 1992.
17.
LogunC., MullolJ., RievesR.D., HoffmanA., JohnsonC., MillerR., GoffJ., KalinerM.A., and ShelhamerJ.H.Use of a monoclonal antibody enzyme linked immunosorbent assay to measure human respiratory glycoprotein production in vitro.Am J Respir Cell Mol Biol5: 71–79, 1991.
18.
MullolJ., RaphaelG.D., LundgrenJ.D., BaraniukJ.N., MéridaM., ShelhamerJ.H., KalinerM.A.Comparison of human nasal mucosal secretion in vivo and in vitro.J Allergy Clin Immunol89: 584–592, 1992.
19.
MullolJ., ReivesR.D., LundgrenJ.D., BaraniukJ.N., MéridaM., HausfeldJ.H., ShelhamerJ.H., KalinerM.A.The effects of neuropeptides on mucous glycoprotein secretion from human nasal mucosa in vitro.Neuropeptides21: 231–238, 1992.
20.
RaphaelG.R., BaraniukJ.N., KalinerM.A.How and why the nose runs.J Allergy Clin Immunol87: 457–467, 1991.
21.
OkayamaM., BaraniukJ.N., MeridaM., KalinerM.Muscarinic receptor subtypes in human nasal mucosa: Characterization, autoradiographic localization, and function in vitro.Am J Respir Cell Mol Biol8: 176–187, 1993.
22.
BaraniukJ.N., KalinerM.A., BarnesP.J.Localization of m3 muscarinic receptor mRNA in human nasal mucosa.Am J Rhinol6: 145–148, 1992.
